These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 16557215)

  • 41. Current colorectal cancer screening strategies: overview and obstacles to implementation.
    Rex DK
    Rev Gastroenterol Disord; 2002; 2 Suppl 1():S2-11. PubMed ID: 12439393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colorectal cancer screening among men and women in the United States.
    Peterson NB; Murff HJ; Ness RM; Dittus RS
    J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening and surveillance of colorectal cancer.
    Kahi CJ; Rex DK
    Gastrointest Endosc Clin N Am; 2005 Jul; 15(3):533-47, ix. PubMed ID: 15990056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
    Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
    Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J; Eichhorn C; Nagel E
    Z Gastroenterol; 2006 Nov; 44(11):1127-34. PubMed ID: 17115353
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors associated with screening for colorectal cancer in a population-based sample.
    Stamatakis KA; Simoes EJ; Brownson RC; Vradenburg J; Murayi T
    Mo Med; 2002 Jul; 99(7):279-85. PubMed ID: 12198998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer screening: present strategies and future prospects.
    Marshall JB
    Postgrad Med; 1996 Mar; 99(3):253-64. PubMed ID: 8637834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Beliefs, risk perceptions, and gaps in knowledge as barriers to colorectal cancer screening in older adults.
    Berkowitz Z; Hawkins NA; Peipins LA; White MC; Nadel MR
    J Am Geriatr Soc; 2008 Feb; 56(2):307-14. PubMed ID: 18070002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter?
    Vernon SW; Tiro JA; Vojvodic RW; Coan S; Diamond PM; Greisinger A; Fernandez ME
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):758-67. PubMed ID: 18381467
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colorectal cancer screening: do we practice what we preach?
    Colquhoun P; Weiss EG; Efron J; Nogueras JJ; Vernava AM; Wexner SD
    Surg Innov; 2006 Jun; 13(2):81-5. PubMed ID: 17012147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer.
    Lindholm E; Brevinge H; Haglind E
    Br J Surg; 2008 Aug; 95(8):1029-36. PubMed ID: 18563785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colorectal cancer: a summary of the evidence for screening and prevention.
    Wilkins T; Reynolds PL
    Am Fam Physician; 2008 Dec; 78(12):1385-92. PubMed ID: 19119558
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Colorectal cancer screening in young patients with poor health and severe comorbidity.
    Sultan S; Conway J; Edelman D; Dudley T; Provenzale D
    Arch Intern Med; 2006 Nov; 166(20):2209-14. PubMed ID: 17101938
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Colorectal cancer screening remains underutilized: CDC report.
    Cancer Pract; 2001; 9(4):159-60. PubMed ID: 11879304
    [No Abstract]   [Full Text] [Related]  

  • 58. Colorectal cancer screening: an overview of available methods and current recommendations.
    Early DS
    South Med J; 1999 Mar; 92(3):258-65. PubMed ID: 10094264
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival of patients diagnosed with colorectal cancer through a television-advertised screening program.
    Slusser SO; Liberski SM; McGarrity TJ
    Am J Gastroenterol; 1996 Aug; 91(8):1563-6. PubMed ID: 8759662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vital signs: Colorectal cancer screening, incidence, and mortality--United States, 2002-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):884-9. PubMed ID: 21734636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.